Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 5Terminated 1

Sponsor Class

INDUSTRY 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 7Sarcoma 6Lymphoid 6Genitourinary 5Tumor-Agnostic 4Other hematologic neoplasm 4Plasma cell 3CNS 3Thoracic 2Other solid neoplasm 2Myeloid 2Gynecologic 2Breast 2Dermatologic 1

Conditions

Kidney Neoplasms 3Prostatic Neoplasms 1Neoplasms 1Liver Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 117Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Cyclophosphamide 44Radiosurgery 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × perifosine × Genitourinary × Clear all
NCT00448721 2018-03-01

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

AEterna Zentaris

Phase 2 Completed
24 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00498966 2018-02-05

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

AEterna Zentaris

Phase 2 Completed
50 enrolled
Genitourinary

Kidney Neoplasms

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

AEterna Zentaris

Phase 1 Completed
30 enrolled
GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT00399152 2014-02-19

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

AEterna Zentaris

Phase 1 Completed
15 enrolled
Genitourinary

Kidney Neoplasms

NCT00060437 2013-06-19

Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡